T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Clinical trial NCT05035407 · TERMINATED

Trial details

NCT number: NCT05035407
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Kita-kyushu Lung Cancer Antigen 1, Human

Start date: 2022-03-08
Primary completion: 2025-07-16
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.